Sachin Shah of Emkay Investment Managers is of the view that one may see 5-7 percent downside in Sun Pharmaceutical Industries.
first published: Jun 1, 2015 02:03 pm
A collection of the most-viewed Moneycontrol videos.
Sensex, Nifty resume rally after 2-day pause, financials shine bright | Closing Bell
Maran Govindasamy of Unifi Capital on Investment Insights from India’s Consumption Story
Nifty Bulls Likely To Tread With Caution With Eye On Axis Bank Q2 Earnings |Opening Bell Live
Live: Nifty slips below 25,200, LG Electronics shares down after blockbuster debut | Closing Bell
You are already a Moneycontrol Pro user.